MedTrace Logo

Agonist Replacement Therapy for Cocaine Dependence

NCT00697138 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2012-03-01

No results posted yet for this study

Summary

Cocaine dependence is a significant public health concern. The proposed research will provide important clinical information regarding the efficacy of agonists replacement therapies for managing cocaine dependence.

Conditions

  • Cocaine Dependence

Interventions

DRUG

d-Amphetamine; Atomoxetine

Dexedrine (0-60 mg/day); Strattera (0-80 mg/day)

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Kentucky

    lead OTHER

Principal Investigators

  • Craig R Rush, Ph.D. · University of Kentucky

Study Design

Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00697138 on ClinicalTrials.gov